Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Stevens

Showing results (81-90 of 485) with videos related to

Pageof 49
Sort By:
The Journal of Clinical Investigation|May 1, 1972
Interferon, antibody, and other host factors in herpes zosterD A Stevens, T C Merigan
Infection and Immunity|August 1, 1991
Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolatesC J Morrison, D A Stevens
Antimicrobial Agents and Chemotherapy|October 1, 1976
Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum sizeJ N Galgiani, D A Stevens
Perception & Psychophysics|January 1, 1988
Responses by humans to oral chemical irritants as a function of locus of stimulationH T Lawless, D A Stevens
The Journal of Antimicrobial Chemotherapy|September 1, 1993
Therapeutic efficacy of a liposomal formulation of amphotericin B (AmBisome) against murine blastomycosisK V Clemons, D A Stevens
Current Opinion in Investigational Drugs (London, England : 2000)|March 14, 2002
The treatment of pulmonary aspergillomaM A Judson, D A Stevens
Mycopathologia|March 1, 1986
Studies with a plant fungicide, imazalil, with vapor-phase activity, in the therapy of human alternariosisR L Stiller, D A Stevens
Antimicrobial Agents and Chemotherapy|October 1, 1991
Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosisK V Clemons, D A Stevens
Antimicrobial Agents and Chemotherapy|March 1, 1995
Efficacy of the triazole D0870 in a murine model of systemic histoplasmosisK V Clemons, D A Stevens
Cancer|July 15, 1985
Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literatureA M Sugar, D A Stevens
Pageof 49

Showing results (81-90 of 485) with videos related to

Sort By:
Pageof 49
The Journal of Clinical Investigation|May 1, 1972
Interferon, antibody, and other host factors in herpes zosterD A Stevens, T C Merigan
Infection and Immunity|August 1, 1991
Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolatesC J Morrison, D A Stevens
Antimicrobial Agents and Chemotherapy|October 1, 1976
Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum sizeJ N Galgiani, D A Stevens
Perception & Psychophysics|January 1, 1988
Responses by humans to oral chemical irritants as a function of locus of stimulationH T Lawless, D A Stevens
The Journal of Antimicrobial Chemotherapy|September 1, 1993
Therapeutic efficacy of a liposomal formulation of amphotericin B (AmBisome) against murine blastomycosisK V Clemons, D A Stevens
Current Opinion in Investigational Drugs (London, England : 2000)|March 14, 2002
The treatment of pulmonary aspergillomaM A Judson, D A Stevens
Mycopathologia|March 1, 1986
Studies with a plant fungicide, imazalil, with vapor-phase activity, in the therapy of human alternariosisR L Stiller, D A Stevens
Antimicrobial Agents and Chemotherapy|October 1, 1991
Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosisK V Clemons, D A Stevens
Antimicrobial Agents and Chemotherapy|March 1, 1995
Efficacy of the triazole D0870 in a murine model of systemic histoplasmosisK V Clemons, D A Stevens
Cancer|July 15, 1985
Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literatureA M Sugar, D A Stevens
Pageof 49